Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/2/2017 |
| Start Date: | September 2005 |
| End Date: | July 2006 |
Compassionate Use Study to Assess the Long Term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in One Patient Following Termination of the SHIELD Open-label Study 2001060
This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl
in a patient who completed two other protocols (2000098 and 2001060.
in a patient who completed two other protocols (2000098 and 2001060.
Inclusion Criteria:
- No inclusion criteria as the patient to be included is this compassionate use
protocol is currently receiving azimilide therapy
Exclusion Criteria:
- Currently taking Class I or other Class III antiarrhythmic drug or other drugs that
may prolong QT interval.
- Is unwilling or unable to give or understand informed consent.
We found this trial at
1
site
Click here to add this to my saved trials
